14
Participants
Start Date
November 1, 2020
Primary Completion Date
November 1, 2021
Study Completion Date
November 1, 2023
Dexmedetomidine Hydrochloride
The continuous intravenous infusion of dexmedetomidine (0.1mg/ml) will start at 0.1ug/kg/h, increasing every 20 minutes by a step change of 0.05-0.2ug/kg/h to reach the target heart rate with the expectation that this should be within 12 hours. The infusion will be reduced by step change, and if necessary, ultimately stopped if the heart rate fall below 80b.p.m..
Esmolol Hydrochloride
The continuous intravenous infusion of esmolol (10mg/ml) will start at 20mg/h, increasing every 20 minutes by a step change of 20mg/h to reach the target heart rate with the expectation that this should be within 12 hours. The infusion will be reduced by step change, and if necessary, ultimately stop if the heart rate fall below 80b.p.m..
Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing
Tibet Autonomous Region People's Hospital
OTHER
Xinchen Wang
OTHER